The heart and cardiovascular problems in rheumatoid arthritis Review article
Article Sidebar
Published:
Sep 30, 2018
Keywords:
arrhythmia, coronary heart disease, heart failure, pericarditis, rheumatoid arthritis, valve diseases
Main Article Content
Abstract
Rheumatoid arthritis is inflammatory, autoimmune, connective tissue disease characterized by destruction of small and medium joints and extra-articular organ involvement, including the cardiovascular system. This group of patients are prone to develop pericarditis, coronary heart disease, heart failure, valve diseases and arrhythmia. Heart and cardiovascular manifestations of rheumatoid arthritis are common and associated with an increased mortality compared with the general population. Therefore, right assessment of cardiovascular disease risk factors, prevention, early diagnosis and treatment of cardiovascular complications is extremely important in patients with rheumatoid arthritis.
Article Details
How to Cite
Świderska, A., Wojciechowska , M., Mamcarz , A., & Cudnoch-Jędrzejewska, A. (2018). The heart and cardiovascular problems in rheumatoid arthritis. Medycyna Faktow (J EBM), 9(3(32), 206-210. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2220
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Aletaha D., Neogi T., Silman A.J. et al.: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 2010; 69: 1580-1588.
2. Ahlmén M., Svensson B., Albertsson K. et al.: Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage. Ann. Rheum. Dis. 2010; 69: 230-233.
3. Nowak B.: Adalimumab w RZS. Przegląd Reumatologiczny 2007; 2: 1-2.
4. Stachowicz K., Śliwińska-Stańczyk P., Łącki J.K.: Znaczenie badania echokardiograficznego w ocenie patologii układu sercowo-naczyniowego u pacjentów z reumatoidalnym zapaleniem stawów. Reumatologia 2009; 47: 82-84.
5. Kitas G., Banks M.J., Bacon P.A.: Cardiac involvement in rheumatoid disease. Clin. Med. 2001; 1: 18-21.
6. Van der Heide A., Jacobs J.W., Bijlsma J.W. et al.: The effectiveness of early treatment with second line anti-rheumatic drugs; a randomized, controlled trial. Ann. Int. Med. 1996; 124: 699-707.
7. Solomon D.H., Goodson N.J., Katz J.N. et al.: Patterns of cardiovascular risk in rheumatoid arthritis. Ann. Rheum. Dis. 2006; 65: 1608-1612.
8. Maradit-Kremers H., Crowson C.S., Nicola P.J. et al.: Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005; 52: 402-411.
9. Krishnan E., Lingala V.B., Singh G.: Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 2004; 110: 1774-1779.
10. Goodson N.J., Symmons D.P., Scott D.G. et al.: Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year follow-up study of a primary care-based inception cohort. Arthritis Rheum. 2005; 52: 2293-2299.
11. Maradit-Kremers H., Nicola P.J., Crowson C.S. et al.: Cardiovascular death in rheumatoid arthritis: a popu-lation-based study. Arthritis Rheum. 2005; 52: 722-732.
12. Turesson C., McClelland R.L., Christianson T.J. et al.: Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2007; 66: 70-75.
13. Gonzalez-Juanatey C., Llorca J., Testa A. et al.: Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003; 82: 407-413.
14. Doria A., Shoenfeld Y., Wu R. et al.: Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2003; 62: 1071-1077.
15. Douglas K.M., Pace A.V., Treharne G.J. et al.: Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann. Rheum. Dis. 2006; 65: 348-353.
16. Banks M., Flint J., Bacon P.A. et al.: Rheumatoid arthritis is an independent risk factor for ischaemic heart disease. Arthritis Rheum. 2000; 43: 385.
17. Warrington K.J., Kent P.D., Frye R.L. et al.: Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res. Ther. 2005; 7: 984-991.
18. Choi H.K., Hernan M.A., Seeger J.D. et al.: Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002; 359: 1173-1177.
19. Micha R., Imamura F., Wyler von Ballmoos M. et al.: Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am. J. Cardiol. 2011; 108: 1362-1370.
20. Jamnitski A., Visman I.M., Peters M.J. et al.: Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study. Ann. Rheum. Dis. 2010; 69: 1929-1933.
21. MacGowan G.A., Mann D.L., Kormos R.L. et al.: Circulating interleukin-6 in severe heart failure. Am. J. Cardiol. 1997; 79: 1128-1131.
22. Rudominer R.L., Roman M.J., Devereux R.B. et al.: Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum. 2009; 60: 9-22.
23. Davis III J.M., Roger V.L., Crowson C.S. et al.: The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum. 2008; 9: 2603-2611.
24. Wislowska M., Sypula S., Kowalik I.: Echogcardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol. Int. 1999; 18: 163-169.
25. Mandell B.F., Hoffman G.S.: Rheumatic diseases and the cardiovascular system. Braunwald’s Heart Disease. A Textbook of Cardiovascular Medicine. Elsevier Saunders, Philadelphia 2005: 2101-2116.
2. Ahlmén M., Svensson B., Albertsson K. et al.: Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage. Ann. Rheum. Dis. 2010; 69: 230-233.
3. Nowak B.: Adalimumab w RZS. Przegląd Reumatologiczny 2007; 2: 1-2.
4. Stachowicz K., Śliwińska-Stańczyk P., Łącki J.K.: Znaczenie badania echokardiograficznego w ocenie patologii układu sercowo-naczyniowego u pacjentów z reumatoidalnym zapaleniem stawów. Reumatologia 2009; 47: 82-84.
5. Kitas G., Banks M.J., Bacon P.A.: Cardiac involvement in rheumatoid disease. Clin. Med. 2001; 1: 18-21.
6. Van der Heide A., Jacobs J.W., Bijlsma J.W. et al.: The effectiveness of early treatment with second line anti-rheumatic drugs; a randomized, controlled trial. Ann. Int. Med. 1996; 124: 699-707.
7. Solomon D.H., Goodson N.J., Katz J.N. et al.: Patterns of cardiovascular risk in rheumatoid arthritis. Ann. Rheum. Dis. 2006; 65: 1608-1612.
8. Maradit-Kremers H., Crowson C.S., Nicola P.J. et al.: Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005; 52: 402-411.
9. Krishnan E., Lingala V.B., Singh G.: Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 2004; 110: 1774-1779.
10. Goodson N.J., Symmons D.P., Scott D.G. et al.: Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year follow-up study of a primary care-based inception cohort. Arthritis Rheum. 2005; 52: 2293-2299.
11. Maradit-Kremers H., Nicola P.J., Crowson C.S. et al.: Cardiovascular death in rheumatoid arthritis: a popu-lation-based study. Arthritis Rheum. 2005; 52: 722-732.
12. Turesson C., McClelland R.L., Christianson T.J. et al.: Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2007; 66: 70-75.
13. Gonzalez-Juanatey C., Llorca J., Testa A. et al.: Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003; 82: 407-413.
14. Doria A., Shoenfeld Y., Wu R. et al.: Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2003; 62: 1071-1077.
15. Douglas K.M., Pace A.V., Treharne G.J. et al.: Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann. Rheum. Dis. 2006; 65: 348-353.
16. Banks M., Flint J., Bacon P.A. et al.: Rheumatoid arthritis is an independent risk factor for ischaemic heart disease. Arthritis Rheum. 2000; 43: 385.
17. Warrington K.J., Kent P.D., Frye R.L. et al.: Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res. Ther. 2005; 7: 984-991.
18. Choi H.K., Hernan M.A., Seeger J.D. et al.: Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002; 359: 1173-1177.
19. Micha R., Imamura F., Wyler von Ballmoos M. et al.: Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am. J. Cardiol. 2011; 108: 1362-1370.
20. Jamnitski A., Visman I.M., Peters M.J. et al.: Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study. Ann. Rheum. Dis. 2010; 69: 1929-1933.
21. MacGowan G.A., Mann D.L., Kormos R.L. et al.: Circulating interleukin-6 in severe heart failure. Am. J. Cardiol. 1997; 79: 1128-1131.
22. Rudominer R.L., Roman M.J., Devereux R.B. et al.: Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum. 2009; 60: 9-22.
23. Davis III J.M., Roger V.L., Crowson C.S. et al.: The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum. 2008; 9: 2603-2611.
24. Wislowska M., Sypula S., Kowalik I.: Echogcardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol. Int. 1999; 18: 163-169.
25. Mandell B.F., Hoffman G.S.: Rheumatic diseases and the cardiovascular system. Braunwald’s Heart Disease. A Textbook of Cardiovascular Medicine. Elsevier Saunders, Philadelphia 2005: 2101-2116.